Riad Sherif

Company: Oculis

Job title: Chief Executive Officer

Seminars:

One Step Closer – First Topical Candidate in Phase III Development for Diabetic Macular Edema 2:30 pm

Enabling the formulation of drugs as topical eye drop treatment with improved solubility, higher concentration, longer residence time, and enhanced bioavailability in eye tissues, including the retina Sharing phase III clinical trials data to leverage learnings for the development of non-invasive ophthalmic drug delivery Achieving reduced ocular inflammationRead more

day: Conference Day Two